$1.75B in CY2024 Part D spend1.2M claims · 216K beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Cariprazine used for?
Cariprazine treats schizophrenia, bipolar disorder, and related conditions by modulating dopamine and serotonin receptors.
Is there a generic for Cariprazine?
No. Cariprazine is brand-only with no generic equivalents currently in market.
How much does my plan pay for Cariprazine?
Across 329 Part D plans, Cariprazine averages $50.95/unit (NADAC). Lowest available: $50.91/unit. Highest in distribution: $50.96/unit.
Is Cariprazine on the FDA shortage list?
No. Cariprazine is not currently on the FDA Drug Shortage Database.
7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (6 approvals on file) · NADAC unit costs: CMS NADAC weekly file (6 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.